glp 1 microdose tirzepatide What Is Microdosing GLP-1s, and Is It Safe? The Best Microdose GLP-1 Programs

I understand Kaiser removed these from base coverage in 2025, but some employers opted to add this benefit

More seriously, Qsymia can cause birth defects

Other GLP-1 receptor agonists, different medications, and non-drug treatments can all play a role in managing diabetes and supporting weight loss

Loss of Muscle Mass: Ongoing calorie restriction may result in loss of muscle mass which will be detrimental to overall health and maintaining weight loss after discontinuation

Some areas operate tier 3 weight management services that could provide access

As the GLP-1 landscape continues to evolve, the goal is no longer simply deciding whether to cover these medicationsbut determining how to maximize their value for both employees and employer-sponsored health plans.